project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6P; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.73; rna integrity number: 9.6; age at index: 72; days to birth: -26560; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 26560; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 457.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 329; initial weight: 340.0; sample id: 3c71158d-98ff-4ef5-923f-ba31a25036ec; sample submitter id: TCGA-DK-AA6P-01A; portion id: f0f38812-2556-4ee3-918c-780c4704930e; portion submitter id: TCGA-DK-AA6P-01A-11; slide id: e2677252-a0ba-4fb9-8f17-f53b14cabba5; slide submitter id: TCGA-DK-AA6P-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 70.0; section location: TOP;